177 related articles for article (PubMed ID: 31236700)
1. Association of oral toxicity and taste changes during hematopoietic stem cell transplantation: a preliminary study.
Ferreira MH; Mello Bezinelli L; de Paula Eduardo F; Lopes RM; Pereira AZ; Hamerschlack N; Corrêa L
Support Care Cancer; 2020 Mar; 28(3):1277-1287. PubMed ID: 31236700
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation.
Scordo M; Shah GL; Adintori PA; Knezevic A; Devlin SM; Buchan ML; Preston EV; Lin AP; Rodriguez NT; Carino CA; Nguyen LK; Sitner NC; Barasch A; Klang MG; Maloy MA; Mastrogiacomo B; Carlow DC; Schofield RC; Slingerland AE; Slingerland JB; Stein-Thoeringer CK; Lahoud OB; Landau HJ; Chung DJ; van den Brink MRM; Peled JU; Giralt SA
Cancer; 2022 Nov; 128(21):3850-3859. PubMed ID: 36041227
[TBL] [Abstract][Full Text] [Related]
3. Salivary antioxidant enzymes associated with oral toxicity in haematopoietic cell transplantation: An observational study.
Bezinelli LM; Eduardo FP; Ferreira MH; Gobbi M; Lopes RMG; Rosin FCP; Vogel C; Hamerschlak N; Corrêa L
Eur J Clin Invest; 2021 Feb; 51(2):e13379. PubMed ID: 32959899
[TBL] [Abstract][Full Text] [Related]
4. Photobiomodulation minimizes taste changes during hematopoietic cell transplantation: A randomized clinical trial.
Ferreira MH; Bezinelli LM; de Paula Eduardo F; Pereira AZ; Hamerschlak N; Corrêa L
J Biophotonics; 2024 Jun; ():e202400095. PubMed ID: 38850248
[TBL] [Abstract][Full Text] [Related]
5. Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT.
Boer CC; Correa ME; Miranda EC; de Souza CA
Bone Marrow Transplant; 2010 Apr; 45(4):705-11. PubMed ID: 19767788
[TBL] [Abstract][Full Text] [Related]
6. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation.
Epstein JB; Phillips N; Parry J; Epstein MS; Nevill T; Stevenson-Moore P
Bone Marrow Transplant; 2002 Dec; 30(11):785-92. PubMed ID: 12439702
[TBL] [Abstract][Full Text] [Related]
7. The experience of dysgeusia in allogeneic haematopoietic cell transplantation survivors: a qualitative study.
Bomben D; Bin A; Venturini M; Bulfone T; Ghirotto L; Bressan V
Support Care Cancer; 2019 Dec; 27(12):4607-4613. PubMed ID: 30937598
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention.
Okada N; Hanafusa T; Abe S; Sato C; Nakamura T; Teraoka K; Abe M; Kawazoe K; Ishizawa K
Support Care Cancer; 2016 Sep; 24(9):3979-85. PubMed ID: 27129837
[TBL] [Abstract][Full Text] [Related]
9. Taste dysfunction in patients undergoing hematopoietic stem cell transplantation: Clinical evaluation in children.
Majorana A; Amadori F; Bardellini E; Campus G; Conti G; Strohmenger L; Schumacher RF; Polimeni A
Pediatr Transplant; 2015 Aug; 19(5):571-5. PubMed ID: 26046542
[TBL] [Abstract][Full Text] [Related]
10. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
Blijlevens N; Schwenkglenks M; Bacon P; D'Addio A; Einsele H; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vokurka S; Quinn B; McCann S;
J Clin Oncol; 2008 Mar; 26(9):1519-25. PubMed ID: 18268357
[TBL] [Abstract][Full Text] [Related]
11. A cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation.
Sato T; Konuma T; Miwa Y; Sugihara N; Tsuru Y; Narita H; Kiriyama S; Kato S; Oiwa-Monna M; Kobayashi K; Takahashi S; Tojo A
Ann Hematol; 2017 Nov; 96(11):1841-1847. PubMed ID: 28815326
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient.
Eduardo FP; Bezinelli LM; Gobbi M; Rosin FCP; Carvalho DLC; Ferreira MH; da Silva CC; Hamerschlak N; Corrêa L
Support Care Cancer; 2019 Mar; 27(3):839-848. PubMed ID: 30109488
[TBL] [Abstract][Full Text] [Related]
13. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
14. Impact of Oral and Gastrointestinal Mucositis on Body Weight Alterations during Hematopoietic Stem Cell Transplantation.
Eduardo FP; Bezinelli LM; Gobbi MF; Pereira AZ; Vogel C; Hamerschlak N; Corrêa L
Nutr Cancer; 2018; 70(2):241-248. PubMed ID: 29278934
[TBL] [Abstract][Full Text] [Related]
15. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
Chen J; Seabrook J; Fulford A; Rajakumar I
J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
[TBL] [Abstract][Full Text] [Related]
16. [Influences of FLU/BU and FLU/MEL on incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients].
Torihata S; Mukai T; Uchihashi T; Matsunaga K; Miki H; Yasumoto M; Yasutake N; Ashida A; Enomoto A; Hamada S; Ashida T
Rinsho Ketsueki; 2017; 58(3):197-203. PubMed ID: 28381685
[TBL] [Abstract][Full Text] [Related]
17. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
Slack JL; Dueck AC; Fauble VD; Sproat LO; Reeder CB; Noel P; Khera N; Betcher JA; Klein JL; Leis JF; Adams RH
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1167-74. PubMed ID: 23664940
[TBL] [Abstract][Full Text] [Related]
18. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
[TBL] [Abstract][Full Text] [Related]
19. Oral health as a predictive factor for oral mucositis.
Coracin FL; Santos PS; Gallottini MH; Saboya R; Musqueira PT; Barban A; Chamone Dde A; Dulley FL; Nunes FD
Clinics (Sao Paulo); 2013 Jun; 68(6):792-6. PubMed ID: 23778491
[TBL] [Abstract][Full Text] [Related]
20. Effect of salivary stimulation therapies on salivary flow and chemotherapy-induced mucositis: a preliminary study.
Pimenta Amaral TM; Campos CC; Moreira dos Santos TP; Leles CR; Teixeira AL; Teixeira MM; Bittencourt H; Silva TA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):628-37. PubMed ID: 22668621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
